What you should know:
1. The alliance aims to be a leading voice on musculoskeletal biologics and regenerative medicine.
2. The alliance was founded in 2018 to evaluate current guidance around biologics-based treatments. They aim to advocate for the responsible use of biologics by developing a scientific basis for the treatments.
The alliances’ board is led by the following leading voices in the orthopedics community:
- Brian Cole, MD, of Chicago-based Rush University
- Jason Dragoo, MD, of Denver-based University of Colorado
- Christian Lattermann, MD, of Boston-based Brigham and Women’s Hospital
- Bert Mandelbaum, MD, of Los Angeles-based Cedars-Sinai Kerlan-Jobe Institute
- Louis McIntyre, MD, of Hempstead, N.Y.-based Hofstra University
- Norimasa Nakamura, MD, of Osaka University Hospital in Japan
- Scott Rodeo, MD, of New York City-based Hospital for Special Surgery
- John Tokish, MD, of Phoenix-based Mayo Clinic Arizona
- Ken Zaslav, MD, of Lynchburg-based OrthoVirginia
More articles on healthcare:
Orthofix’s M6-C cervical disc in 2019: 7 key developments
Dr. Robert Brady: How the 2020 CMS final rule will affect the spine field
How OrthoNY is trying to solve its recruiting problem
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
